Skip to Content
Merck
CN
  • Disentangling the molecular determinants for Cenp-F localization to nuclear pores and kinetochores.

Disentangling the molecular determinants for Cenp-F localization to nuclear pores and kinetochores.

EMBO reports (2018-04-11)
Alessandro Berto, Jinchao Yu, Stéphanie Morchoisne-Bolhy, Chiara Bertipaglia, Richard Vallee, Julien Dumont, Francoise Ochsenbein, Raphael Guerois, Valérie Doye
ABSTRACT

Cenp-F is a multifaceted protein implicated in cancer and developmental pathologies. The Cenp-F C-terminal region contains overlapping binding sites for numerous proteins that contribute to its functions throughout the cell cycle. Here, we focus on the nuclear pore protein Nup133 that interacts with Cenp-F both at nuclear pores in prophase and at kinetochores in mitosis, and on the kinase Bub1, known to contribute to Cenp-F targeting to kinetochores. By combining in silico structural modeling and yeast two-hybrid assays, we generate an interaction model between a conserved helix within the Nup133 β-propeller and a short leucine zipper-containing dimeric segment of Cenp-F. We thereby create mutants affecting the Nup133/Cenp-F interface and show that they prevent Cenp-F localization to the nuclear envelope, but not to kinetochores. Conversely, a point mutation within an adjacent leucine zipper affecting the kinetochore targeting of Cenp-F KT-core domain impairs its interaction with Bub1, but not with Nup133, identifying Bub1 as the direct KT-core binding partner of Cenp-F. Finally, we show that Cenp-E redundantly contributes together with Bub1 to the recruitment of Cenp-F to kinetochores.

MATERIALS
Product Number
Brand
Product Description

Roche
Anti-GFP, from mouse IgG1κ (clones 7.1 and 13.1)
Sigma-Aldrich
Anti-GAL4, Activation domain antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody, buffered aqueous solution